174 related articles for article (PubMed ID: 7474920)
21. [Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study].
Nolte M; Werner M; Spann W; Schnabel B; von Wasielewski R; Wilkens L; Georgii A
Pathologe; 1993 Dec; 14(6):302-6. PubMed ID: 8121883
[No Abstract] [Full Text] [Related]
22. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
[TBL] [Abstract][Full Text] [Related]
23. Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction.
Said JW; Sassoon AF; Shintaku IP; Kurtin PJ; Pinkus GS
Am J Pathol; 1991 Feb; 138(2):261-4. PubMed ID: 1899539
[TBL] [Abstract][Full Text] [Related]
24. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
25. [Hodgkin lymphomas ar negative with regard to bcl-2/JH gene rearrangement, but partly express BCL-2 protein: analysis of 83 cases from the German Hodgkin Trial].
Nolte M; Werner M; von Wasielewski R; Wilkens L; Fischer R; Hübner K; Georgii A
Verh Dtsch Ges Pathol; 1994; 78():329-33. PubMed ID: 7534007
[TBL] [Abstract][Full Text] [Related]
26. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
[TBL] [Abstract][Full Text] [Related]
27. Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms.
Jiwa NM; Oudejans JJ; Bai MC; Van den Brule AJ; Horstman A; Vos W; Van der Valk P; Kluin PM; Walboomers JM; Meijer CJ
Histopathology; 1995 Jun; 26(6):547-53. PubMed ID: 7665145
[TBL] [Abstract][Full Text] [Related]
28. The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma.
LeBrun DP; Ngan BY; Weiss LM; Huie P; Warnke RA; Cleary ML
Blood; 1994 Jan; 83(1):223-30. PubMed ID: 8274737
[TBL] [Abstract][Full Text] [Related]
29. Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.
Jiwa NM; Kanavaros P; van der Valk P; Walboomers JM; Horstman A; Vos W; Mullink H; Meijer CJ
J Clin Pathol; 1993 Mar; 46(3):211-7. PubMed ID: 8385158
[TBL] [Abstract][Full Text] [Related]
30. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: correlation with chromosome translocations.
Murty VV; Ladanyi M; Houldsworth J; Mikraki V; Chaganti RS
Diagn Mol Pathol; 1992 Dec; 1(4):221-8. PubMed ID: 1342969
[TBL] [Abstract][Full Text] [Related]
31. Incidence of Epstein-Barr virus bcl-2 expression and chromosomal translocation t(14;18) in large cell lymphoma associated with paragranuloma (lymphocyte-predominant Hodgkin's disease).
Hansmann ML; Shibata D; Lorenzen J; Hell K; Nathwani BN; Fischer R
Hum Pathol; 1994 Mar; 25(3):240-3. PubMed ID: 8150454
[TBL] [Abstract][Full Text] [Related]
32. In situ hybridization for the detection of low copy numbers of c-abl oncogene mRNA in lymphoma cells: technical approach and comparison with results with anti-oncoprotein antibodies.
Greil R; Fasching B; Huber H
Lab Invest; 1989 Apr; 60(4):574-82. PubMed ID: 2651801
[TBL] [Abstract][Full Text] [Related]
33. The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.
Athan E; Chadburn A; Knowles DM
Am J Pathol; 1992 Jul; 141(1):193-201. PubMed ID: 1632463
[TBL] [Abstract][Full Text] [Related]
34. Preservation of functional and regulatory domains of expressed bcl-2 genes in non-Hodgkin's lymphoma.
Dirks W; Nolte M; Werner M; Jäger K; Koch C; Drexler HG
Leukemia; 1996 Jan; 10(1):150-8. PubMed ID: 8558921
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte predominance Hodgkin's disease (nodular paragranuloma)--a bcl-2 negative germinal centre lymphoma.
Algara P; Martinez P; Sanchez L; Villuendas R; Orradre JL; Oliva H; Piris MA
Histopathology; 1991 Jul; 19(1):69-75. PubMed ID: 1916688
[TBL] [Abstract][Full Text] [Related]
36. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.
Liu YJ; Mason DY; Johnson GD; Abbot S; Gregory CD; Hardie DL; Gordon J; MacLennan IC
Eur J Immunol; 1991 Aug; 21(8):1905-10. PubMed ID: 1868875
[TBL] [Abstract][Full Text] [Related]
37. The prognostic relevance of apoptosis-related proteins in classical Hodgkin's lymphomas.
Vassallo J; Metze K; Traina F; de Souza CA; Lorand-Metze I
Leuk Lymphoma; 2003 Mar; 44(3):483-8. PubMed ID: 12688319
[TBL] [Abstract][Full Text] [Related]
38. The bcl-2 gene and protein in malignant lymphomas.
Cleary ML
Bull Cancer; 1991; 78(2):187-93. PubMed ID: 1903662
[TBL] [Abstract][Full Text] [Related]
39. [Hodgkin's disease--an entity?].
Hansmann ML
Verh Dtsch Ges Pathol; 1992; 76():24-36. PubMed ID: 1283267
[TBL] [Abstract][Full Text] [Related]
40. Antiapoptotic marker Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12.
Chu WS; Aguilera NS; Wei MQ; Abbondanzo SL
Hum Pathol; 1999 Sep; 30(9):1065-70. PubMed ID: 10492041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
